A STUDY OF IPRONIAZID TREATMENT IN CHRONIC AKINETIC PATIENTS
Abstract
One hundred chronic, withdrawn, akinetic, psychotic patients were given iproniazid in hopes of making them more accessible to group interaction and more manageable. We did not find the drug helpful in those patients whose affect was characterized by apathy and flatness. On the other hand, the drug appeared to be definitely useful in one-half of those cases where the primary symptom was depression. Serious side effects may result from the drug and dosage must be very carefully adjusted for each patient.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
